Whitehawk Therapeutics (WHWK) Interest & Investment Income (2016 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Interest & Investment Income of -$135000.0 for Q1 2026, down 800.0% year-over-year from $19285.7 in Q1 2025, and up 97.01% quarter-over-quarter from -$4.5 million in Q4 2025.
Powered by 
Analysis
Whitehawk Therapeutics (WHWK) Interest & Investment Income (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Interest & Investment Income for 7 consecutive years, with -$135000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 800.0% year-over-year to -$135000.0; the TTM figure through Mar 2026 stood at -$2.8 million (down 158.37% YoY), while the FY2025 annual figure was $104000.0, down 97.35% from the prior year.
- Interest & Investment Income rose to -$135000.0 in Q1 2026 per WHWK's latest filing, from -$4.5 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.9 million in Q4 2024 and bottomed at -$4.5 million in Q4 2025.
- Historically, Interest & Investment Income has averaged $632764.7 across 5 years, with a median of $620000.0 in 2022.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 15700.0% — and 2026, when it tumbled 800.0%.
- Whitehawk Therapeutics' Interest & Investment Income stood at $1.6 million in 2022, then declined by 6.66% to $1.5 million in 2023, then surged by 160.87% to $3.9 million in 2024, then tumbled by 215.41% to -$4.5 million in 2025, then jumped by 97.01% to -$135000.0 in 2026.
- Business Quant data shows WHWK's Interest & Investment Income at -$135000.0 in Q1 2026, -$4.5 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Whitehawk Therapeutics | 377.13 Mn | 377.13 Mn | - | 1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | -135,000.00 |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.98 Mn |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 676,000.00 |
| Sep 30, 2024 | 906,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.64 Mn |
| Mar 31, 2023 | 1.66 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 620,000.00 |
| Jun 30, 2022 | 158,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 12,000.00 |
| Jun 30, 2021 | 1,000.00 |